Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashis K Saha

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of the Association of Physicians of India|April 11, 2015
Mucosal bridge in oesophagusAshis K Saha, Arup K Kundu
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Novel beta-(imidazol-4-yl)-beta-amino acids: solid-phase synthesis and study of their inhibitory activity against geranylgeranyl protein transferase type IAshis K Saha, David W End
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Novel triazole based inhibitors of Ras farnesyl transferaseAshis K Saha, Li Liu, Richard Simoneaux, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Sylvie G Bernier, Elisabeth Doyle, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Sylvie G Bernier, Malcolm J Kavarana, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRAPatrick Angibaud, Ashis K Saha, Xavier Bourdrez, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2009
Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Alexander L Satz, Sylvie G Bernier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MSAshis K Saha, Xiang Yu, Jian Lin, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of the Association of Physicians of India|April 11, 2015
Mucosal bridge in oesophagusAshis K Saha, Arup K Kundu
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Novel beta-(imidazol-4-yl)-beta-amino acids: solid-phase synthesis and study of their inhibitory activity against geranylgeranyl protein transferase type IAshis K Saha, David W End
Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Novel triazole based inhibitors of Ras farnesyl transferaseAshis K Saha, Li Liu, Richard Simoneaux, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
Exploration of amino alcohol derivatives as novel, potent, and highly selective sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Sylvie G Bernier, Elisabeth Doyle, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2008
Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Sylvie G Bernier, Malcolm J Kavarana, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2003
4-methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the farnesyltransferase inhibitor ZARNESTRAPatrick Angibaud, Ashis K Saha, Xavier Bourdrez, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2009
Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonistsGhotas Evindar, Alexander L Satz, Sylvie G Bernier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MSAshis K Saha, Xiang Yu, Jian Lin, et al.
Pageof 1